T. Rowe Price Associates’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,322
| Closed | -$983K | – | 3032 |
|
|
2024
Q2 | $983K | Buy |
36,322
+1,417
| +4% | +$38.3K | ﹤0.01% | 1905 |
|
|
2024
Q1 | $640K | Buy |
34,905
+1,490
| +4% | +$27.3K | ﹤0.01% | 2107 |
|
|
2023
Q4 | $411K | Buy |
33,415
+5,152
| +18% | +$63.4K | ﹤0.01% | 2257 |
|
|
2023
Q3 | $424K | Buy |
28,263
+3,818
| +16% | +$57.3K | ﹤0.01% | 2192 |
|
|
2023
Q2 | $795K | Buy |
24,445
+1,370
| +6% | +$44.6K | ﹤0.01% | 1908 |
|
|
2023
Q1 | $903K | Buy |
23,075
+4,299
| +23% | +$168K | ﹤0.01% | 1835 |
|
|
2022
Q4 | $992K | Buy |
18,776
+3,203
| +21% | +$169K | ﹤0.01% | 1777 |
|
|
2022
Q3 | $701K | Buy |
15,573
+2,254
| +17% | +$101K | ﹤0.01% | 1947 |
|
|
2022
Q2 | $485K | Buy |
13,319
+295
| +2% | +$10.7K | ﹤0.01% | 2227 |
|
|
2022
Q1 | $538K | Buy |
13,024
+686
| +6% | +$28.3K | ﹤0.01% | 2296 |
|
|
2021
Q4 | $526K | Buy |
12,338
+2,375
| +24% | +$101K | ﹤0.01% | 2364 |
|
|
2021
Q3 | $548K | Sell |
9,963
-49
| -0.5% | -$2.7K | ﹤0.01% | 2336 |
|
|
2021
Q2 | $479K | Buy |
10,012
+2,149
| +27% | +$103K | ﹤0.01% | 2405 |
|
|
2021
Q1 | $398K | Buy |
7,863
+821
| +12% | +$41.6K | ﹤0.01% | 2468 |
|
|
2020
Q4 | $444K | Buy |
7,042
+3,726
| +112% | +$235K | ﹤0.01% | 2291 |
|
|
2020
Q3 | $223K | Buy |
+3,316
| New | +$223K | ﹤0.01% | 2390 |
|
|
2020
Q2 | – | Sell |
-90,870
| Closed | -$2.86M | – | 2543 |
|
|
2020
Q1 | $2.86M | Sell |
90,870
-5,403
| -6% | -$170K | ﹤0.01% | 1424 |
|
|
2019
Q4 | $3.89M | Sell |
96,273
-4,100
| -4% | -$166K | ﹤0.01% | 1444 |
|
|
2019
Q3 | $3.27M | Buy |
+100,373
| New | +$3.27M | ﹤0.01% | 1447 |
|